Impax Labs Inc (IPXL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPXL | SUPN | TSHA | ||
| Company | Impax Labs Inc | Supernus Pharm | Taysha Gene Therapies Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.20 | 33.69 | 2.28 | ||
| High | 18.95 | 34.00 | 2.35 | ||
| Low | 17.40 | 33.00 | 2.19 | ||
| Last | 18.30 | 33.27 | 2.31 | ||
| Change | unch | -0.38 | +0.03 | ||
| % Change | unch | -1.13% | +1.32% | ||
| Volume | 3,041,000 | 494,400 | 1,489,200 | ||
| 20-Day Average Volume | 870,975 | 608,820 | 1,335,540 | ||
| Previous Close | 18.30 | 33.65 | 2.28 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 19.17 | 30.54 | 2.19 | ||
| 20-Day Raw Stochastic | 26.47% | 89.50% | 84.44% | ||
| 20-Day Relative Strength | 43.41% | 66.72% | 48.66% | ||
| Weighted Alpha | +16.20 | +15.81 | -11.09 | ||
| Today's Opinion | N/A | 56% Buy | 32% Sell | ||
| Previous Opinion | N/A | 56% Buy | 40% Sell | ||
| Last Month's Opinion | N/A | 24% Sell | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.68% since 04/27/18 | +4.23% since 08/07/24 | +13.79% since 08/07/24 | ||
| Low | 17.40 on 05/04/18 | 31.21 on 08/08/24 | 1.99 on 08/12/24 | ||
| High | 20.80 on 05/02/18 | 34.00 on 08/14/24 | 2.35 on 08/14/24 | ||
| 1-Month | |||||
| %Chg | -7.34% since 04/04/18 | +16.25% since 07/12/24 | -2.53% since 07/12/24 | ||
| Low | 17.40 on 05/04/18 | 27.05 on 08/05/24 | 1.93 on 08/05/24 | ||
| High | 20.80 on 05/02/18 | 34.00 on 08/14/24 | 2.51 on 07/16/24 | ||
| 3-Month | |||||
| %Chg | -5.67% since 02/02/18 | +14.84% since 05/14/24 | -10.12% since 05/14/24 | ||
| Low | 17.40 on 05/04/18 | 25.53 on 06/14/24 | 1.83 on 06/26/24 | ||
| High | 21.55 on 02/26/18 | 34.00 on 08/14/24 | 4.32 on 06/13/24 | ||
| 6-Month | |||||
| %Chg | -1.35% since 11/03/17 | +20.72% since 02/14/24 | +58.22% since 02/14/24 | ||
| Low | 15.60 on 12/07/17 | 25.53 on 06/14/24 | 1.44 on 02/15/24 | ||
| High | 21.75 on 01/26/18 | 35.44 on 03/21/24 | 4.32 on 06/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,351,821 | 1,849,875 | 426,401 | ||
| Shares Outstanding, K | 73,870 | 54,974 | 187,018 | ||
| Annual Sales | 775,790,000 | 607,520,000 | 15,450,000 | ||
| Annual Net Income | -469,290,000 | 1,320,000 | -111,570,000 | ||
| Last Quarter Sales | 182,910,000 | 168,330,000 | 3,410,000 | ||
| Last Quarter Net Income | -301,070,000 | 19,920,000 | -24,060,000 | ||
| 60-Month Beta | 1.15 | 0.90 | 0.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.11 on 03/01/18 | 0.36 on 08/06/24 | -0.10 on 05/14/24 | ||
| Latest Earnings Date | 05/09/18 | 08/06/24 | 08/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 29.05 | 359.89 | 68.00 | ||